retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not sure if this is a significant loss to the board of ILI.
"("ILI" or the "Company") (TSXV:ILI) announces the resignation of Michel Boily from its Board of Directors. The Company thanks Mr. Boily for his years of service and wishes him well in his future endeavors.
About Infinite Ore Corp.
Infinite Ore Corp. is a junior mining exploration company focused on seeking and acquiring world-class mineral projects globally. Our current focus is on properties with the potential for VMS mineralization in the Confederation Mineral Belt near Red Lake, Ontario, and the Jackpot Lithium property located near Nipigon, Ontario. Infinite also continues to evaluate suitable prospects that fit the mandate of the company."
OK time to make a bold prediction on the Stock Market. Why? Because my ego says “give it a shot”
Disclaimer, I am no expert and record is no better tor worse than most. But on a roll with my “don’t catch a Knive” call.
First, assuming there is NO cure or vaccine announced in the next 4 months, I see the Market dropping at least 15% from today. Possibly 20% for a brief period.
However, I also believe by August or September news of a vaccine may be a reality and that should mark that the bottom of the Market has been seen. The USA election then determines the future.
We live in “INTERESTING” times.
Any comments?
Change in a member of the board
"RELIQ HEALTH TECHNOLOGIES, INC. ANNOUNCES NEW US-BASED CHIEF MEDICAL OFFICER
Reliq Health Technologies Inc. has appointed Illinois-based Dr. Joyce Johnson as its new chief medical officer.
"We are thrilled to welcome Dr. Joyce Johnson to the Reliq team as our Chief Medical Officer," said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. "Dr. Johnson is Board Certified in Family Medicine and practices at KSB Hospital in Dixon, IL. She completed her residency with the University of Illinois College of Medicine at Rockford, Dixon Rural Training Track. Her expertise and experience working with patients in rural communities in the US is a perfect fit for Reliq. Dr. Johnson has a unique understanding of the impact that chronic diseases have on patients and their families, as her father was on at-home peritoneal dialysis for kidney disease for many years. Her knowledge of the US health system and experience working with Medicare and Medicaid patients will be invaluable to Reliq as we continue to rapidly grow our business in the States. Dr. Johnson is a Canadian expat and completed her undergraduate degree at McMaster University in Reliq's hometown of Hamilton, Ont."
"I am very excited to be joining Reliq as its Chief Medical Officer," said Dr. Johnson. "I am passionate about Reliq's mission to improve access to care for remote and rural patients. It is so important to ensure continuity of care for chronic disease patients in the community to achieve better health outcomes. In this time of COVID-19 it is vital that we limit the risk of exposure for vulnerable populations like seniors and those with underlying medical conditions. The iUGO Care platform gives patients access to their care team from the comfort and safety of their own homes. Keeping these patients healthy and at home can help free up critical healthcare resources for COVID-19 patients."
The Company would like to thank outgoing CMO Dr. Richard Sztramko for his contributions to Reliq, and wish him the best in his clinical practice during this incredibly challenging time for frontline healthcare providers.
About Reliq Health Technologies
Reliq is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq's powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits."
UGLY
An anonymous director reports
CANNTRUST OBTAINS INITIAL ORDER UNDER COMPANIES' CREDITORS ARRANGEMENT ACT (CANADA)
Canntrust Holdings Inc. has obtained an order from the Ontario Superior Court of Justice (Commercial List) granting protection under the Companies' Creditors Arrangement Act (Canada). In accordance with the Initial Order, all creditors of Canntrust, Canntrust Inc., CTI Holdings (Osoyoos) Inc., and Elmcliffe Investments Inc. (the "Applicants"), as well as the plaintiffs in the putative class actions and other litigation brought against the Applicants, will be stayed from enforcing their claims. The Initial Order provides for a stay of proceedings in favour of the Applicants for an initial period of 10 days, subject to such extensions as the Court may subsequently order, and the appointment of Ernst & Young Inc. as Monitor in the CCAA proceedings.
After reviewing a number of options, Canntrust's Board of Directors determined that commencing CCAA proceedings is in the Company's best interests. The Company hopes to exit CCAA protection well-positioned to rebuild its stakeholders' trust and deliver high-quality, innovative products to its patients and customers.
Pursuant to the Initial Order, the Court has granted a stay of proceedings that will allow Canntrust to, among other things:
Complete the remainder of Canntrust's remediation plan for its Vaughan Facility without disruption and submit the related evidence package to Health Canada;
Continue to work with Health Canada to resolve any remaining Cannabis Act compliance issues, with a view towards reinstating Canntrust's licenses for its Niagara and Vaughan facilities and restoring operations;
Explore a CCAA plan of compromise or arrangement as a means for addressing the multiple putative class actions and other litigation brought against Canntrust in several jurisdictions, seeking to resolve all of the claims and contingent claims against the Company in a single forum; and
Facilitate the completion of the Board of Directors' review of strategic alternatives (the "Strategic Process"), including the solicitation, development and execution of any potential sale or other strategic transaction involving Canntrust, whether in addition to, or as an alternative to, a CCAA plan of compromise or arrangement.
Despite the efforts by Canntrust's management and Board of Directors to preserve the Company's cash liquidity while seeking to restore the Company to operations and resolve the multiple litigations and other contingent claims facing the Company, the Company's future remains uncertain. Without its cannabis licenses, the Company has been unable to generate any meaningful revenue since June 2019. The Company has not filed any financial statements subsequent to its interim unaudited comparative financial statements for the three months ended March 31, 2019, which, together with its financial statements for the year ended December 31, 2018, are subject to restatement. Furthermore, the effects of the COVID-19 pandemic have exacerbated what were already difficult circumstances, introducing potential delays in Health Canada's ability to review the Company's applications for reinstatement of its Niagara and Vaughan licenses and making it even more challenging for Canntrust to attract new financing or a strategic partner.
Canntrust is expending significant time and money pursuing the completion of its remediation plan and defending the putative class actions against the Company in multiple jurisdictions. There can be no assurance that Health Canada will reinstate Canntrust's licenses or that the Company's litigation will be resolved in the near term or on a basis that will leave the Company with sufficient financial resources to resume operations. At present, and in light of seeking CCAA protection, its reduced liquidity position and the contingent claims it is facing, the Company does not intend to devote additional time or money towards curing its public disclosure defaults by completing and resuming the filing of required reports under Canadian and United States securities laws. As of March 20, 2020, Canntrust had a cash balance of approximately $145 million. If Health Canada elects to reinstate Canntrust's cannabis licenses, it would take several months for the Company to begin earning revenue and the Company would require significant working capital to restore its operations and return to profitability. Similarly, there can be no assurance that the Strategic Process will result in any transaction, and there can be no assurance that the Strategic Process or the outcome of the CCAA proceeding will provide any residual value for the benefit of holders of the Company's Common Shares.
Trading in Canntrust's common shares (the "Common Shares") on the Toronto Stock Exchange (the "TSX") and New York Stock Exchange (the "NYSE") has been halted and the Company expects that, as a result of having filed for protection under the CCAA, the Common Shares will soon be delisted from trading on the TSX and NYSE. In addition, Canntrust anticipates that, as a result of the Company's filing for protection under the CCAA, its pending delisting by the TSX and NYSE, and its continuing default of its disclosure obligations under applicable securities laws, provincial securities regulators in Canada will issue a cease trade order to prevent any trading in the Common Shares in Canada.
A comeback hearing in respect of the relief granted pursuant to the Initial Order will be scheduled within ten days (the "Comeback Hearing"). Interested parties that wish to bring a motion at the Comeback Hearing are required to provide notice to the affected parties prior to the Comeback Hearing pursuant to the requirements set forth in the Initial Order.
A copy of the Initial Order and other information will be available on the Monitor's website at http://www.ey.com/ca/Canntrust.
Company's .04 dividend protected.
" ("Newport" or the "Company") is pleased to provide shareholders and investors with an update on its quarterly dividend payment schedule as a result of recent global activity in the oil markets. As the Company's Gross Overriding Royalty ("GOR") business model relies upon the operations of Beach Energy Ltd ("Beach") in Australia, the Company is also providing a summary of a news release made by Beach dated March 27th, 2020.
The economic shut down from COVID-19 has resulted in a reduction in demand for crude oil and petroleum products worldwide. Also, failure of the OPEC + countries to agree on a reduction of supply by 1.5mmbpd and the subsequent price war between Russia and Saudi Arabia has plunged the global financial markets into turmoil. Crude oil, as a global commodity, has been extremely negatively affected during the past several weeks resulting in a great deal of uncertainty in the sector.
What is already certain is that significant capex cuts are being made by most producers, with energy companies cutting and deferring costs wherever they can. At the same time oil production from North American companies is declining, bank capital substantially reduced; in some cases banks are refusing energy companies access to credit facilities that were already in place, with other companies in breach of their debt covenants. As a consequence, dividends in energy companies are being slashed or suspended. This latter point is obviously of concern to shareholders and potential investors in Newport.
As stated in a Company News release dated, February 10th, 2020, "The Company's strong balance sheet ensures that Newport has the ability to maintain regular quarterly dividend payments with a reduced likelihood that the quarterly dividend payments would be cut in any sector downturn".
That statement is still valid and Management remains confident in the Company's ability to weather the current oil price disruption. After the recent dividend payment the Company has over $6 million in the treasury, no debt, and will not need to incur any debt or sell any assets in order to remain solvent and/or to pay dividends. Furthermore, the Company is well positioned to maintain a solid balance sheet even if the oil price stays at USD$25/bbl through 2020 and 2021 without the need to raise any additional capital. This was achieved in early 2016 when the low oil price at that time was followed by a V-shaped recovery. However, with uncertainty of such a recovery in 2020, and without knowing the medium to long term economic effects of the COVID-19 pandemic, it is difficult to predict what's next for the oil sector.
The Company's ability to maintain its dividend schedule is subject to Beach continuing to produce oil and gas from their Cooper Basin operations. Beach are extremely well positioned to weather the current oil price storm. In its news release of March 27th, 2020, entitled 'Business Update', Beach make several key points relevant to Newport's 2.5% GOR. These are summarized as follows:
At the end of February 2020 Beach had AUD$151M net cash, with access to over AUD$600M in liquidity via a AUD$450M committed revolving credit facility.
Western Flank oil assets are low cost producers, with field operating costs of approximately AUD$5/bbl.
Revenues from Beach's gas business cover all their group operating and stay-in-business costs; projected FY2021 free cash flow break-even oil price is less than US$0/bbl.
Beach's actual realized oil price in January and February 2020 was AUD$100/bbl.
Beach crude oil sells at a material premium to the Brent Crude oil price and the declining Australian dollar provides a further buffer against lower US dollar oil prices.
Beach is well positioned to manage an extended period of low oil prices, as well as the impact of the Covid-19 pandemic.
While its strong balance sheet means Beach is well placed to continue growth investment, in recognizing the current downturn, it is being prudent in targeting up to a 30% deferral in FY2021 capital investment relative to its previous guidance.
Obviously, Newport's management will re-examine the Company's dividend schedule on the basis of Beach's FY2020 Financial Results and any revised guidance. At the present time shareholders should be aware that Newport can support the current quarterly dividend schedule, and Beach is in an incredibly strong position to handle the current market disruption."
More additions to the revenue stream. We can expect many more such agreements. Limitation is the ability to add the participants to our platform.
(“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has signed a contract with MedTech Evolutions, LLC (“MedTech”) in Kentucky, USA, to provide its iUGO Care platform to over 27,000 eligible Medicare patients in Alabama, Illinois, Mississippi and Tennessee.
“We are thrilled to be working with MedTech Evolutions to bring our iUGO Care platform to their clients,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “MedTech’s clients provide care to over 27,000 chronic disease patients in Alabama, Illinois, Mississippi and Tennessee. We will be deploying our Remote Patient Monitoring (RPM), Care Chronic Care Management (CCM), Behavioral Health Integration (BHI) and Psychiatric Collaborative Care Services (CoCM) to these patients to help improve health outcomes and enhance access to care. The iUGO Care platform allows patients to receive high quality healthcare from the comfort of their own homes, reducing the risk of exposure to the novel coronavirus for these particularly vulnerable populations.”
Reliq will be providing its iUGO Care platform and associated support services to MedTech Evolutions’ clients. Onboarding is expected to begin in April. Each patient on the platform will generate approximately $65 USD per month in SaaS and support services revenue.
“We chose to partner with Reliq Health to provide their iUGO Care platform to our clients because their solution is comprehensive, flexible and powerful,” said Brien Shea of MedTech Evolutions. “With the support services Reliq can offer to our clients through their Call Center and their cutting edge technology, they offer a solution that is secure, robust and fits the needs of our clients and strategic relationships for improved patient outcomes and experience.”
About MedTech Evolutions, LLC
MedTech Evolutions, LLC is a comprehensive healthcare solutions provider focused predominantly on telemedicine products and digital services for the chronic care market, both urban and rural. MedTech Evolutions also serves the broader healthcare sector and its individual segments from hospital to home care, with a focus on improving patient outcomes, achieving healthcare delivery congruities and lowering the costs associated with healthcare delivery. Learn more at https://medtechevolutions.com/.
About Reliq Health
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
Finally, full disclosure from management so that shareholders can see the status of the company-its potential and plannings!
"THE FLOWR CORPORATION ANNOUNCES RESTRUCTURING PROGRAM AND PROVIDES CORPORATE UPDATE
The Flowr Corp. has restructured approximately 25 per cent of its work force globally, which is expected to result in an annual reduction of head count expenses in excess of approximately $6-million. In an effort to tighten the timeline toward becoming cash flow positive in second half 2020, the company has decided to focus its resources near term on the Premium Canadian dried flower market, specifically to continue building on the positive sales momentum it has been seeing with its Flowr-branded B.C. Pink Kush and other high THC (tetrahydrocannabinol) strains, expected to be launched in the marketplace in 2020.
"The changes we announced today were part of an ongoing comprehensive review of our operations to reduce costs, focus on the highest-value priorities and accelerate cash flow generation, in addition to some of the anticipated macroeconomic headwinds stemming from COVID-19. This was an extremely difficult decision that we did not take lightly and would like to thank former and current employees for their tremendous contributions. The resulting company will be a leaner, more efficient organization. Our fundamental thesis that consumers demand quality dried flower has been proven correct as evidenced by heavy demand for our flagship strain, B.C. Pink Kush. We also look forward to the release of our newest high THC strains B.C. Louis XIII and B.C. Tahoe OG in the coming months. Given that our Kelowna 1 facility is now fully operational, we expect to see a step function change in production and sales beginning in the second quarter. While we continue to be very optimistic about our derivative form factor product plans, in light of the current macroenvironment, we feel it's prudent to delay further material investments in these areas and focus on our core competency -- producing premium indoor-grown dried flower and building the Flowr brand in the Canadian recreational market," commented Vinay Tolia, chief executive officer of Flowr.
Operational updates: Canada
The company has advanced its Kelowna campus to be a single hub for all aspects of cultivation, processing and packaging to service the Canadian cannabis market. The company has only invested in either highly controlled indoor growing environments for premium high THC dried cannabis (Kelowna 1) or low-cost outdoor and shade-house production for extraction (Flowr Forest). Notably, the company has not invested in traditional greenhouses, which are more expensive to build and operate, because it believes that they cannot produce premium smokable products. Flowr has proven that low-cost outdoor and shade-house grows provide quality inputs, especially for use in extraction. Recently, the company launched new corporate and Canadian recreational websites, consistent with its brand marketing strategies.
Kelowna 1 indoor facility:
On Feb. 24, 2020, the company announced it had received approval from Health Canada to open an additional 10 grow rooms, bringing the total to 20 at the facility. The ultimate production capacity is expected to be approximately 10,000 kilograms of premium cannabis when fully optimized.
Since that announcement, the company has propagated seven of the newly licensed grow rooms with the remaining three to be planted within the next 30 days.
The company has taken preventative measures to remain a reliable supply chain partner during the COVID-19 pandemic.
Outdoor and shade-house facility (Flowr Forest):
The company has decided to delay the launch of its live resin product until its Canadian dried flower operations are generating positive cash flow.
As a result, the company has decided to selectively plant outdoors to enable optionality for a full outdoor grow to support its revised live resin launch plans.
Flowr/Hawthorne research and development facility
Flowr and Hawthorne have entered a strategic R&D alliance to build a state-of-the-art, 45,000-square-foot R&D facility, the first of its kind in Canada:
Construction of the R&D facility is substantially complete. The company submitted the evidence package to Health Canada to license the first floor on Feb. 24, 2020, and expects to receive licensing approval in second quarter 2020.
Once operational, the R&D facility will allow Flowr to stay on the leading edge of cultivation technology and maximize plant health and yields.
Global operations
Portugal
Sintra, Portugal, indoor facility
Sintra is a highly controlled indoor cultivation, extract processing and finished product packaging facility. Construction of the facility is substantially complete with three of the six total grow rooms currently operational. Obtaining GMP (good manufacturing practice) certification is both a critical step to the production and sales of a high-value medicinal product, which can be distributed to any country within the European Union and is Flowr's priority within its Holigen business.
The company had its final GMP inspection in September, 2019, and still anticipates receipt of EU-GMP certification.
Construction of the Sintra facility is substantially complete.
Aljustrel, Portugal
Aljustrel is a seven-million-square-foot outdoor cultivation facility, which has been deemed a project of national interest by the Portuguese government, the only cannabis-related project to receive this designation. The company expects a phased ramp-up of production at Aljustrel to match capacity with the revenue potential of an expanding European medicinal cannabis market.
The company plans to plant over one million square feet of cultivation area in 2020 with a harvest expected in fourth quarter 2020.
Australia
The company maintains its GMP-compliant packaging facility in Australia. Flowr expects its assets in Australia to be a hub for distribution and sales of medicinal cannabis into the Australasian region:
During the first quarter, Holigen Australia received a modest shipment of premium dried flower from its Kelowna 1 facility to be sold and distributed into the Australian market.
Financial update
Further to the company's announcement on Nov. 19, 2019, relating to the entering into of a credit agreement with ATB Financial for access to debt financing of up to $25-million, on Feb. 28, 2020, the company completed its second drawdown of $3.2-million from its term facility and $500,000 from its revolving operating credit facility under the credit agreement. Furthermore, the company is assessing various financing alternatives to address near-term working capital needs.
About The Flowr Corp.
Flowr is a Toronto-headquartered cannabis company with operations in Canada, Europe and Australia. Its Canadian operating campus, located in Kelowna, B.C., includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility that is currently under construction. Internationally, Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a licence for cannabis cultivation in Portugal and will operate GMP-designed manufacturing facilities in Portugal and Australia.
Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products.
At this stage any news is positive
" ("Kontrol" or "Company") a leader in the energy efficiency sector through IoT, Cloud and SaaS technology today announced that it will be presenting at this year's Spring Investor Summit on March 25th-26th.
During the current climate of concern, The Spring Investor Summit will now take place virtually, featuring over 500 registered executives and investors.
Investors will still be able to view all the company presentations directly in the conference event platform on the event days. 1:1's will now be scheduled and conducted via phone lines with a dedicated PIN for each meeting.
You can view our company presentation via webcast here: https://www.webcaster4.com/Webcast/Page/2038/33697 on March 25th, 2020 at 2:40 p.m. EST.
About Kontrol Energy
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions."
This is a possible hope from the group that solved the EBOLA crisis with their vaccine.
Researchers in Winnipeg claim they're close to launching a treatment for COVID-19.
Emergent BioSolutions is creating two COVID-19 treatments out of the University of Manitoba.
The treatments use antibodies that bind with the virus to help the body fight it.
"You think of it as sort of a piece of our immune system that grabs hold of that virus or bacteria and helps us deal with it," Dr. Laura Saward, the senior vice president and therapeutics business unit head at Emergent BioSolutions.
One treatment uses antibodies from previously infected patients, and the other collects antibodies from vaccinated horses.
The treatments are not vaccines and are to be used as a way to help patients recover or to protect people exposed to the virus in the short-term.
"These are treatments that you'd use as a rescue therapy to help people that are sick with the virus in hospital, as well as a way to use it to prevent infection," said Saward.
The team has created a number of drugs using this platform and said bringing new drugs, like the COVID-19 treatments, is a familiar process.
"I think everyone is very focused on trying to put all of our best legs and knowledge there on this outbreak to try to limit its impact," Saward said.
She said the company started focusing on COVID-19 back in January.
A clinical trial of the treatments will be held in about four months.
"What we are targeting with our plasma collection already started, is that we have product available by the end of summer," said Dr. Saward.
Update from management emphasizes the ability of the company to meet the challenges of the current COVID-19 pandemic problem. All we need is the Market to recognize the potential of this company.
(“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, would like to provide shareholders with the following corporate update.
“The COVID-19 pandemic is obviously an unprecedented event for Reliq as it is for every other business worldwide,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies. “During this time of uncertainty we wanted to let our shareholders know that we continue to provide the full range of iUGO Care software solutions and services to our clients remotely. In keeping with the CDC’s recommendations, many of our clients are urgently moving to a virtual care model to reduce the risk of virus transmission associated with in-office and in-home visits. Our clients provide care to patients who are at the highest risk for poor outcomes from COVID-19 infection – elderly individuals with multiple underlying chronic conditions – and we are responding to our customers’ urgent need to protect and care for this vulnerable population remotely. Our new clients in Florida (Comprehensive Partners and Direct Access at Home) and Louisiana (Blum Telehealth) are onboarding patients to the iUGO Care platform this month and have now requested that we accelerate onboarding significantly relative to their original schedules. In Texas, the Department of State Health Services has issued guidance recommending that Home Health Care providers conduct visits virtually wherever possible, and we are providing our clients there with expanded features and support to meet these evolving needs. Our clients are able to use the iUGO Care platform to communicate virtually with their patients, monitor patients’ existing chronic conditions, evaluate patients for symptoms of COVID-19 infection (fever, cough, shortness of breath) and document risk factors such as travel or exposure to anyone who has tested positive for the virus. Our platform enables care providers to remotely triage patients and determine who needs further screening or emergency care, and to collect and transmit critical information to public health units in their region. The Company is able to provide all training, onboarding and support services remotely. Further, since we have a substantial inventory of biometric monitoring devices there are no supply chain issues currently impacting or expected to impact deployments going forward. This is an extraordinarily difficult time for high risk patients and the clinicians who provide care to them, and we are honoured to be able to contribute to the efforts to prevent and protect.”
Reliq is also pleased to announce that the Company has hired Mr. Matthew Lee as Reliq’s new Chief Financial Officer. Mr. Lee has worked extensively with Canadian companies doing business in the US, and his skill set and network of US tax and accounting professionals will be invaluable to support the anticipated rapid growth of Reliq’s US business. Mr. Lee has experience in audit, finance and public company financial reporting & operations management. He has previously served as Chief Financial Officer for multiple TSX-V and CSE listed companies, and holds a Chartered Professional Accountant designation with a Bachelor of Commerce Degree from the University of British Columbia.
The Company would like to thank outgoing Interim CFO, Mr. Dong Shim, for his service and wish him well in his future endeavors.
About Reliq Health
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits."
A timely update from management re the company's position in the present environment.
"("Kontrol" or "Company") a leader in the energy efficiency sector through IoT, Cloud and SaaS technology provides an update on the novel Coronavirus (COVID-19) impact on Kontrol's operations.
Kontrol's business operations are primarily in Ontario, Canada, however the Company has numerous US customers with approximately ten percent (10%) in US revenues. Kontrol's customers include owners, operators and managers of commercial and industrial facilities. Kontrol has an established and diversified customer base with approximately fifty percent (50%) of Kontrol's annual revenue generated from repeat customer business.
While, to date, Kontrol has not experienced any direct cancellation of orders or projects, numerous customers are following the appropriate Government requirements in Canada and the US to initiate plans to manage on-site access, employee interactions and adhere to various travel bans. These customer actions will have an impact on overall revenues and earnings for 2020 and will vary with the length and duration of the COVID-19 crisis. The sum of these impacts can create variability on quarter over quarter performance.
"We appreciate the fact that we have strong repeat business from our existing customers, and we continue to quote new opportunities," says Paul Ghezzi, CEO of Kontrol. "Kontrol is taking the appropriate measures to work through any customer disruptions. Kontrol will adhere to the policy and procedures put in place by our customers and follow the appropriate on-site protocols that may be required."
In terms of the Company's balance sheet, the majority of Kontrol's existing debt is unsecured and Kontrol has successfully managed to re-finance existing debt as required in the past.
"COVID-19 is a health crisis first and foremast that we believe will be contained by our global health care system," continues Paul Ghezzi. "Kontrol's priority is to ensure the health and safety of its employees, customers, and partners. We continue to monitor the situation closely and at the same time remain focused on executing our strategic growth plans."
About Kontrol Energy
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.
From News Release (C:CGOC) Cannabis Growth Opportunity Corp
Mr. Sean Conacher of Cannabis Growth reports
CGOC ANNOUNCES CLOSING OF CORE ONE LABS DEBENTURE FACILITY AND SHARE-SWAP
Cannabis Growth Opportunity Corp. and Core One Labs Inc. have closed their previously announced convertible debenture facility and share swap. Core One is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. Core One's technology produces infused strips that provide a new way to accurately meter the dosage and assure the purity of the selected cannabinoid constitutes.
Pursuant to the terms of a subscription agreement, the Company has committed to advance up to the principal amount of $1,500,000 (the "Principal") through a non-brokered convertible debenture (the "Convertible Debenture") offering (the "Offering"). The Principal amount of the Convertible Debenture is to be advanced in three equal tranches of $500,000, with part of the first tranche released today (and the balance expected to be advanced this week), and each subsequent tranche to be released upon completion of mutually agreed operational milestones. The Convertible Debenture shall mature on December 31, 2022 and shall bear interest at 12% per annum, calculated and accrued monthly in arrears and due on maturity. The Convertible Debenture is to be secured by a general security agreement covering all of Core One's personal property upon the Company advancing the total Principal amount of the Convertible Debenture. Furthermore, the Principal amount of the Convertible Debenture and any accrued but unpaid interest shall be convertible at the option of the Company into common shares of Core One ("Core One Shares") at anytime prior to maturity at a price of $0.40 per share.
In connection with the Offering, the Company also received 1,500,000 common share purchase warrants of Core One (the "Core One Warrants") that shall vest in three equal tranches upon closing of each advance under the Convertible Debenture. The Core One Warrants shall be exercisable until December 31, 2022 at a price of $0.60 per share. Furthermore, Core One may accelerate the expiration date of the Core One Warrants to a period of 30 days following written notice to the Company in the event that the Core One Shares close at or above $1.50 per share for a period of 10 consecutive trading days on the Canadian Securities Exchange.
In addition, the Company and Core One also entered into subscription agreements to exchange approximately $2,000,000 of each companies' common shares (the "Share-Swap") whereby Core One received a total of 3,149,606 common shares of CGOC, at a deemed price of $0.635 per share, and the Company received a total of 5,333,333 Core One Shares, at a deemed price of $0.375 per share. Pursuant to the Share-Swap, both CGOC and Core One have also signed a voting and resale agreement providing that each party will be required to vote such common shares acquired under the Share-Swap as recommended by the other party and will be restricted from trading such common shares for a period of 18 months. A copy of the voting and resale agreement shall be made available under the Company's issuer profile on SEDAR at www.sedar.com. Furthermore, Core One has also agreed to nominate one board member of Core One as recommended by the Company at future shareholder meetings and the ability, if the Company does not have its nominee on Core One's board of directors, to appoint a board observer.
Brad Eckenweiler, Chief Executive Officer of Core One, commented, "We are excited with the prospect of developing a relationship that will benefit both parties in the United States, Canada and Europe. While CGOC has expertise that can expedite our Canadian goals, I also believe our experience will assist CGOC's interests throughout California."
Sean Conacher, Chief Executive Officer of CGOC, commented, "Core One operates out of a state-of-the-art facility in California and we believe this investment will assist in advancing our interests in the California market. CGOC also believes there is significant opportunities with Core One's infused strip technology and we work to advance this technology globally."
All securities issued pursuant to the Offering and Share-Swap are subject to a mandatory hold period of four months and a day under applicable Canadian securities laws.
Early Warning Disclosure Pursuant to National Instrument 62-103
Prior to the Offering and Share-Swap, CGOC held nil securities of Core One. As of the date hereof, after giving effect to Offering and Share-Swap, the Company beneficially owns or controls 5,333,333 Core One Shares, the Convertible Debenture and 1,500,000 Core One Warrants, representing approximately 16.63% of the issued and outstanding Core One Shares on a non-diluted basis and approximately 28.35% of the issued and outstanding Core One Shares on a partially diluted basis, assuming the conversion of the Convertible Debenture (excluding conversion of any accrued and unpaid interest into Core One Shares) and exercise of all Core One Warrants held by the Company.
Pursuant to the terms of the subscription agreement in respect to the Offering, the Company has agreed to advance an additional $1,000,000 under the Convertible Debenture, to be released upon completion of mutually agreed operational milestones.
The Core One Shares, Convertible Debenture and Core One Warrants were acquired for investment purposes. While Company currently has no plans or intentions with respect to the Core One securities, other than the Company's agreement to advance an additional $1,000,000 under the Convertible Debenture as set out above, the Company may from time to time acquire additional securities of Core One, may sell all or a portion of its securities of Core One or may continue to hold the Core One Shares, Convertible Debenture and Core One Warrants, or other securities of Core One, depending on market conditions, the Company's view of Core One's prospects, other investment opportunities and other factors considered relevant the Company.
A copy of the early warning report to be filed by the Company will be available under Core One's issuer profile on SEDAR at www.sedar.com or by contacting Sean Conacher, CEO at (647) 660-0566. The Company's head office is located at 240 Richmond Street West, Suite 4163, Toronto, Ontario, M5V 1V6.
About Core One
Core One (CSE: COOL) is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. Core One's technology produces infused strips (like breath strips) that are not only a safer, healthier option to other forms of delivery but also superior bioavailability of cannabis constituents. Some strips will also include supplemental co-active ingredients such as nutraceuticals, vitamins and peptides. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on Core One's technology, tests for quality and composition of all the ingredients used in every strip which results in a delivery system that is safe, consistent and effective. In addition, through its efforts to develop a better CannaStripsTM product, Core One has developed considerable expertise in cannabis extraction and nursery activities. The operational expertise developed by Core One as a result of these efforts has created new market opportunities for the company in white label sales.
About CGOC
CGOC is an investment corporation that offers unique global exposure to the emerging global cannabis sector. CGOC's main objective is to provide shareholders long-term total return through its actively managed portfolio of securities, both public and private, operating in, or that derive a portion of their revenue or earnings from products or services related to the cannabis industry.
Only thing management could do.
"DHR) (the "Company" or "Discovery Harbour") announces that, due to the recent extraordinary downturn of global financial market conditions associated with the novel coronavirus outbreak, it is suspending the Company's non-brokered private placement (the "Offering") announced on February 3, 2020 for 30 days, during which time the Company will reassess market conditions to determine whether the Offering will continue. The Company closed the initial tranche of the Offering in the amount of $187,500 pursuant to a news release dated February 25, 2020. Management is hopeful that market conditions will stabilize over the coming weeks so that it can complete the balance of the Offering. However, Management can provide no assurance it can complete the balance of the Offering within the next 30 days given that the market downturn and events which may have caused it are beyond the Company's control.
("PLAN" or the "Company"), an emerging leader in the commercialization of natural pozzolans, is pleased to present a corporate update on the company's activities.
We are accelerating our efforts to commercialize our developing portfolio of natural pozzolan properties. In combination with these efforts, we are seeking to address the massive carbon footprint and requirements of one of the world's largest industries…cement production.
Research Partnership with University of Alberta
Throughout the world, fly ash is generated as a by-product of burning coal for electricity generation. Fly ash is used as a supplementary cementing material in blended cement mixes. The supply of fly ash is directly related to the amount of coal which is combusted in power plants which in many parts of Canada, and the world, are scheduled for decommissioning or already being decommissioned.
In December 2019, PLAN announced a strategic relationship with the University of Alberta to conduct work with respect to improving the slump of the natural pozzolan from its Z-1 Quarry so that it possesses similar rheology to commercially available fly ash.
We have received an interim report from the University which describes the work done to date. The slump has been improved with a combination of various inputs which will remain proprietary; however, one input in the blend which we will disclose is pulverized, recycled glass.
The preliminary results are encouraging and in turn we believe there is tremendous potential for using waste material in a proprietary blend to create a high-quality supplementary cementing material (SCM) for the cement industry as a potential replacement for fly ash.
The initial research trial is expected to conclude at the end of April 2020 at which time we expect to finalize our proprietary formulation for CSA testing. Once CSA testing is completed, we intend to begin production on a small scale to introduce our SCM to the BC and Alberta markets.
Natural Pozzolans
In the fall of 2019, we announced the option of the Z-2 Natural Pozzolan Property. In February 2020, we announced the option of the Z-3 Natural Pozzolan Property (Heffley Creek). These three properties form the core portfolio of natural pozzolan properties for PLAN.
These three high quality properties near Kamloops, BC are all close to rail access to the Lower Mainland and Alberta.
We are currently finalizing the 2020 exploration plans for both the Z-2 and the Z-3 and expect to commence exploration work in late April or early May with work commencing once the snowpack is melted and the ground is sufficiently dry to conduct field work.
The intention for the Z-2 Property is to start to quantify the amount of natural pozzolan contained in an area of the property where we have already confirmed natural pozzolans occur.
For the Z-3 Property, we intend to conduct soil work on the property while completing further testing in areas previously drilled by LaFarge Canada which identified natural pozzolans.
For the Z-1 Property, our COO is working to renew the Notice of Work (license to mine the property) which is up for renewal in July 2020. In the interim, we will continue to draw down on the previously mined stockpile of natural pozzolan as required.
Z-1 Zeolite for Denaturing Cannabis
PLAN is experiencing an increase in the volume of denatured cannabis it is collecting from its contract with one of Canada's largest extraction facilities. The success of utilizing our Z-1 natural pozzolan in the denaturing process has resulted in additional extraction companies requesting samples and pricing. We view supplying Z-1 natural pozzolan to denature cannabis as a growth opportunity in 2020.
Comminution Toll Processing
PLAN completed a small comminution contract in 2019. Comminution is the process of pulverizing rocks into fine powders. Based on industry feedback, PLAN intends to procure additional comminution equipment to enable it to respond to commercial demand for
comminution services. We are targeting soft rock phosphate and limestone companies. This same equipment is used for pulverizing natural pozzolans and will increase our capacity to process our own material. This complementary revenue stream will support our capacity growth for other core initiatives.
Third Party Building Product Development
Over the last six months, PLAN has supplied pulverized natural pozzolan from the Z-1 Quarry to three companies which produce cementitious products. In particular, we are jointly working on product development with one of these companies and on sharing the costs of CSA testing on the building product which we hope will ultimately contain Z-1 pulverized natural pozzolan as a core ingredient.
Commenting on the recent activities and milestones, PLAN's CEO, Steve Harpur, said "We are very excited about the potential for our natural pozzolan assets and affiliated cementitious building products in development to contribute to the effort of reducing the carbon footprint of the cement industry. The PLAN team, which welcomed Mike Wypych as COO in February 2020, is accelerating our efforts to lay the foundation for significant commercialization and expansion in 2020."
"FURA ARRANGES LONG TERM LOAN FACILITY
A very significant loan agreement by the company revealed.
Of note, it is repayable completely at given dates with no mention of shares of Firma being converted to pay the debt. The company holdings are the guarantee for the provider of the funds.
"Fura Gems Inc. has issued a grid promissory note to a private company pursuant to which the lender has agreed to immediately lend and the company has agreed to borrow $21-million (U.S.). An additional US$7,600,000 remains available for drawdown by the Company at a later date, subject to the terms of the Note (the "Second Advance"), for a maximum aggregate principal amount of US$28,600,000. The funds advanced under the Note are initially unsecured, will bear interest at a rate of ten percent per annum and have a maturity date of August 31, 2021. The Initial Advance is inclusive of US$5,543,699 for that certain loan advanced by the Lender to the Company described in the Company's press release dated February 10, 2020. The principal amount of the loan as well as accrued interest will be payable on the maturity date.
Under the terms of the Note, if any amounts payable by the Company to the Lender (the "Obligations") remain outstanding on May 31, 2020, at the request of the Lender, the Company agrees to grant a security interest to the Lender in all of its present and future property (the "Security Interest"). If the Security Interest is not granted to the Lender and the Obligations are not paid in full on or prior to the date that falls six months from the date that the funds are advanced (the "Security Date"), the Company is required to pay an extension fee of US$800,000, which shall form part of the Obligations payable on the maturity date, and the Lender shall extend the Security Date to the date that is 12 months from the date that the funds are advanced (the "Extended Security Date"). If the Security Interest is not granted to the Lender and the Obligations are not paid in full on or prior to the Extended Security Date, the Company is required to pay an additional extension fee of US$800,000, which shall form part of the Obligations payable on the maturity date, and the Lender shall extend the Extended Security Date to the maturity date.
The proceeds of the loan are expected to be used for (i) the advancement of its Coscuez emerald project in Colombia, its ruby projects in Mozambique and its sapphire projects in Australia (ii) general corporate purposes, including paying down debts and (iii) payment towards acquiring ruby mining concession 8955C, ruby mining licence 7414L and a 20% interest in ruby mining concession 8921C, each in the Montepuez district of Mozambique.
The Lender is both a "related party" and a "control person" of the Company pursuant to Canadian securities laws. Issuing the Note to the Lender is therefore considered to be a "related party transaction" under Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101") but is exempted from the requirement to obtain a formal valuation pursuant to 5.5 (b) and from the requirement to obtain minority approval pursuant to 5.7(1)(f) of MI 61-101, as the loan (i) is on reasonable commercial terms that are not less advantageous to the Company than if the loan was obtained from an arm's length party, and (ii) is not convertible, directly or indirectly, into equity or voting securities of the Company or a subsidiary of the Company or repayable as to principal or interest, directly or indirectly, in equity or voting securities of the Company or a subsidiary of the Company. Minority shareholder approval for the Lender becoming a control person of Fura was previously obtained by Fura at its annual and special meeting of shareholders held on August 2, 2019. Please refer to the Company's management information circular dated July 2, 2019 for more information. The Company did not file a material change report more than 21 days before issuing the Note as the terms of the Note were not settled until shortly prior to such issuance, and the Company wished to complete the loan on an expedited basis.
About Fura Gems Inc.
Fura Gems Inc. is a gemstone mining and marketing company which is engaged in the mining, exploration and acquisition of gemstone licences. Fura's headquarters are located in Toronto, Canada and its administrative headquarters are located in the Gold Tower, Dubai. Fura is listed on the TSX Venture Exchange under the ticker symbol "FURA".
Fura is engaged in the exploration of resource properties in Colombia and owns a 76% interest in the Coscuez emerald mine in Boyaca, Colombia. Fura is involved in the exploration and mining of sapphires in Australia through its 100% interests in two mining permits (EPM 25973 and EPM 25978) and three mining licences (ML 70419, ML 70447 and ML 70451), and rubies in Mozambique through its 80% effective interest in four ruby licences (4392L, 3868L, 3869L and 6811L) and its 100% interest in ruby licence 5572L.
MEA CULPA- At my age, I find that IR or AR reports require a genius translator to explain the language used when they describe their services they are providing- their patents,SDK,ImagineARTM,etc.
So this report reads well, but I can't evaluate its significance. As an investor, I can only use revenue reports as a guide post.I've come a long way from movies, and TV programs with this company. Management has tried their best.
(“Imagination Park” or “Company”) is pleased to provide the following corporate updates.
Alen Paul Silverrstieen, CEO of Imagination Park states: “We have expanded our 2020 efforts beyond our existing target market of sports/live events/retail with the SDK product and pursuing new AR market opportunities such as product brand package marketing, musical artists, and eSports leveraging our ImagineARTM portfolio of solutions. We are optimistic for strong revenue growth for 2020.”
ImagineARTM SDK
Imagination Park Technologies is currently scheduled to launch the new ImagineARTM SDK integrated with the Sacramento Kings mobile app within 30 days. The ImagineARTM SDK is a completely new product development for the Company and a native mobile app for both IOS and Android.
ImagineARTM Cloud 2.0
Simultaneously with the mobile SDK, there is a significant new product upgrade of features and functions for the ImagineARTM Cloud in Microsoft Azure. Based upon current analysis and feedback from prospective clients, in addition to the metrics provided via dashboard, additional new features will be integrated: callbacks & data access will be included to continue to facilitate custom analytics.
Milwaukee Auto Show
The AR Scavenger Hunt conducted from February 22 – many attendees enjoyed March 1st at the Wisconsin Center with a sweepstakes winner awarded a prize daily for completing the twenty 3D model hunt collection. The video of this AR Scavenger hunt can be viewed by clicking here.
Additional Patent Status
In May 2019, when Imagination Park Technologies acquired the patent portfolio from XMG Studio Inc., the following patent, US20160325183A1, “Systems and Method for Capture and Use of Local Elements in Gameplay” was included for no additional fee and was classified as ‘abandoned’. The company engaged the original law firm filer, White & Williams, to pursue re-activation of this patent application and is currently in engaged with the USPTO for approval of this specific intellectual property claim.
AGM
Imagination Park Technologies Inc. has mailed out the circular and proxies last week to all shareholders on record as of February 19, 2019. The AGM is scheduled for March 25, 2019 at 11:30am and being held at the offices of ThreeD Capital. The address is 130 Spadina Avenue, Suite 401,Toronto, ON. M5V 2L4.
About Imagination Park
Imagination Park Technologies Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.
MEA CULPA- At my age, I find that IR or AR reports require a genius translator to explain the language used when they describe their services they are providing- their patents,SDK,ImagineARTM,etc.
So this report reads well, but I can't evaluate its significance. As an investor, I can only use revenue reports as a guide post.I've come a long way from movies, and TV programs with this company. Management has tried their best.
(“Imagination Park” or “Company”) is pleased to provide the following corporate updates.
Alen Paul Silverrstieen, CEO of Imagination Park states: “We have expanded our 2020 efforts beyond our existing target market of sports/live events/retail with the SDK product and pursuing new AR market opportunities such as product brand package marketing, musical artists, and eSports leveraging our ImagineARTM portfolio of solutions. We are optimistic for strong revenue growth for 2020.”
ImagineARTM SDK
Imagination Park Technologies is currently scheduled to launch the new ImagineARTM SDK integrated with the Sacramento Kings mobile app within 30 days. The ImagineARTM SDK is a completely new product development for the Company and a native mobile app for both IOS and Android.
ImagineARTM Cloud 2.0
Simultaneously with the mobile SDK, there is a significant new product upgrade of features and functions for the ImagineARTM Cloud in Microsoft Azure. Based upon current analysis and feedback from prospective clients, in addition to the metrics provided via dashboard, additional new features will be integrated: callbacks & data access will be included to continue to facilitate custom analytics.
Milwaukee Auto Show
The AR Scavenger Hunt conducted from February 22 – many attendees enjoyed March 1st at the Wisconsin Center with a sweepstakes winner awarded a prize daily for completing the twenty 3D model hunt collection. The video of this AR Scavenger hunt can be viewed by clicking here.
Additional Patent Status
In May 2019, when Imagination Park Technologies acquired the patent portfolio from XMG Studio Inc., the following patent, US20160325183A1, “Systems and Method for Capture and Use of Local Elements in Gameplay” was included for no additional fee and was classified as ‘abandoned’. The company engaged the original law firm filer, White & Williams, to pursue re-activation of this patent application and is currently in engaged with the USPTO for approval of this specific intellectual property claim.
AGM
Imagination Park Technologies Inc. has mailed out the circular and proxies last week to all shareholders on record as of February 19, 2019. The AGM is scheduled for March 25, 2019 at 11:30am and being held at the offices of ThreeD Capital. The address is 130 Spadina Avenue, Suite 401,Toronto, ON. M5V 2L4.
About Imagination Park
Imagination Park Technologies Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.
Management is smart enough to use the virus situation as an accelerant of their isolation protection of patients with compromised health issues. A win for the company and the patients/ medical staff!
"(“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has signed a contract with Direct Access at Home to provide its iUGO Care Chronic Care Management (CCM) and Behavioral Health Integration (BHI) platform to over 25,000 eligible Medicare patients in Florida. The contract also includes Reliq’s integration partner, Blum Telehealth.
“We are thrilled to be working with Direct Access at Home to provide our iUGO Care Chronic Care Management (CCM) and Psychiatric Collaborative Care Services (CoCM) modules for Behavioral Health Integration to their more than 25,000 Medicare patients throughout Florida,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Studies consistently show that both patients with chronic conditions and physically healthy seniors have better health outcomes, are able to live independently longer and report higher Quality of Life scores when they are provided with access to mental health services. The Centers for Medicare & Medicaid Services (CMS) billing codes that enable clinicians to bill for both CCM and BHI/CoCM recognize the relationship between mental and physical health, and support clinical caregivers who want to treat the whole patient to achieve the best possible outcomes. We are also very pleased to once again be working with our integration partner, Blum Telehealth, on this account.”
Onboarding will start in April and is expected to be completed within the next 6 months. Each patient on the platform will generate an average of $65 USD per month in SaaS and support service fees for Reliq.
“We selected iUGO Care after an extensive review of all available options because the software is secure, easy to use and fits seamlessly with our existing workflows,” said Larry Beuer, CEO of Direct Access at Home. “At Direct Access at Home our mission is to eliminate barriers to care and provide access to high quality health care in the home. Reliq’s iUGO Care platform will help us support our clients’ physical and mental health from the comfort of their own homes, enabling them to preserve their independence and quality of life.”
About Direct Access at Home
Direct Access at Home is a Home Health Care, Care Management and Mental Health Care provider with operations in Florida, Colorado, Illinois, North Carolina and Pennsylvania. Direct Access at Home works in conjunction with medical doctors, home health agencies, assisted living facilities, independent living facilities, skilled nursing facilities, outpatient rehab and hospitals. We provide a Licensed Clinical Social Worker (LCSW) to meet with individuals, couples and family members to help them work through feelings of depression, loneliness, isolation, anxiety, etc. Providing Home Health Care and Mental Health Services in Florida, Colorado, Illinois, North Carolina and Pennsylvania. Direct Access at Home is a Medicare Certified, CHAP accredited home care provider.
About Blum Telehealth
Blum brings together all of your health care providers. Blum can reduce health care costs and expand reach. Blum can reduce health care costs and expand reach for health care providers. Hospitals can refer non-critical patients to practitioners and out of the emergency room. In schools, Blum brings together parent, pediatrician and school nurse to diagnose and treat a sick student without anyone having to leave the office. Almost all facilities can expand reach to underserved populations very cost-efficiently.
About Reliq Health
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
Reassuring response to my question to management re %
engagement of eligible patients of RHT.
"Reliq expects 100% of the patients it announces to go live on the iUGO Platform. Generally the number of available and eligible patients is higher than the number that the Company releases to ensure we hit the number announced. When there is uncertainty in the numbers, or Reliq does not have control of the onboarding, the company only releases the contract details without numbers.
I hope that answers your question".
Best Regards,
Scott Fitzgerald
Investor Relations
I would think that what would give shareholders a better idea of ONBOARDING progress would be the percentage of participation of the available population that agrees to join!!
Is it 100% or 50% or what.
Then all calculations will have SOME reality.
Management has published a review of the potential of the Nevada gold project.
Lengthy and detailed. Shareholders should do DD on this news.
Here are excerpts
Discovery Harbour Resources Corp. has further developed drill targets in three priority target areas, as additional geochemical data add to the Caldera gold property's integrated geologic model. Faustus, Gemina and Harmonia comprise three of a total eight distinct target areas defined on the Caldera property (see Figure 1). Together they form a 6 kilometer trend characterized by consistent alteration, geochemical gold and pathfinder anomalies in soils, and intermittent high-grade gold intercepts in shallow drilling.
Historic shallow drilling in the Faustus Area returned assays up to 7.36 grams per tonne ("g/t") gold over 6.1 m from a chalcedonic vein (see Figure 2), interpreted to be further evidence of leakage from a high grade gold system in the deeper "boiling zone". The Gemina and Harmonia areas have seen relatively little drilling. The Gemina area has a notably long strike length, a series of historical workings, and several rock samples that produced high-grade gold results in assay up to 37 g/t gold. The Harmonia area is characterized by low temperature clay alteration and geochemical pathfinder elements anomalies, an indication that the area is high in the epithermal system.
Mark Fields, Discovery Harbour's President and CEO, commented, "We have a better understanding than ever before of the extent and potential of this mineralized system. The high-grade gold occurrences at or near surface were deposited by a deeper source, and all of the data we've gathered and analyzed support our thesis that this source is intact and a productive low sulphidation epithermal gold system. We look forward to drilling to 300 to 500 meters depth, the first systematic drilling consistently below 100 meters, to test these deeper targets."
The Faustus area contains three targets. The first consists of northwesterly-trending sheeted veins that were drilled to a shallow depth producing good gold intercepts in several holes and at least anomalous results in all holes. Targets within this area demonstrate two contrasting structural trends, one being northwesterly and the other northerly.
Other areas are similarily discussed.
Name change was an obvious move to make.
Lithium prices weak.
We have to hope the new projects find minerals of value.
" ("ILI" or the "Company") (TSXV:ILI) announces that to better reflect the nature of its current mining exploration focus it is changing its name from Infinite Lithium Corp. to Infinite Ore Corp. There will be no changes to the Company's share structure or trading symbol.
The Company's new focus is in the Red Lake district of Ontario after a series of option agreements and acquisitions recently announced. Investors are encouraged to visit our new website located at www.infiniteore.com.
About Infinite Ore Corp.
Infinite Ore Corp. is a junior mining exploration company focused on seeking and acquiring world-class mineral projects globally. Our current focus is on properties with the potential for VMS mineralization in the Confederation Mineral Belt near Red Lake, Ontario, and the Jackpot Lithium property located near Nipigon, Ontario. Infinite also continues to evaluate suitable prospects that fit the mandate of the company.
Hopefully, a lot of information will be available on tomorrow's webinar. You can register right now on their website. The webinar starts at 6 am Pacific/ 9 am Eastern March 3.
And more GOOD news from Australia
" ("Newport" or "the Company") is pleased to report its after tax 2.5% Gross Overriding Royalty ("GOR") payment from Beach Energy Ltd. ("Beach") for the November 2019 to January 2020 quarter.
Gross royalty income for the quarter was AUD$3,602,465. The AUD$2,521,726 payment received by Newport is net of 30% withholding taxes (AUD$1,080,739) in accordance with the Australian Tax Office.
Newport has approximately CDN$7.2 million in its Treasury, comprised of cash, cash equivalents, and short-term investments.
With the success of the drilling programs conducted by Beach for both oil and gas permits over which the Company holds its 2.5% GOR, increased production in the Bauer field, and plans for exploration and development in FY2020, as reported in a Company News Release dated February 11th, 2020, the Company anticipates continuity of production and associated royalty revenues. The Company has a strong balance sheet with no debt and management is confident in its ability to maintain regular quarterly dividend payments as committed to in a News Release dated December 12th, 2019. As announced on February 10th, 2020, Newport's first quarterly dividend payment date is March 9th, 2020.
The Company continues to encourage shareholders and potential investors to access information released independently by Beach and Santos Ltd to keep current during exploration, development and potential production of all the licenses subject to the Company's GOR."
Today's news illustrates the great potential of the Blum Telehealth agreement with RHT. Such major rollouts will ad significant revenue flows to RHT bottom line. BUT management must be careful to make sure financing is available to pay startup costs without over extending the budgets.
A delightful consideration. Slow and steady is the desired mode.
" (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has signed a contract with Blum Telehealth to provide its iUGO Care Chronic Care Management (CCM) and Behavioral Health Integration (BHI) solutions to over 50,000 eligible Medicare patients in Louisiana.
“We are very pleased to be working with Blum Telehealth to bring our iUGO Care Chronic Care Management (CCM) and Behavioral Health Integration (BHI) solutions to more than 50,000 patients throughout Louisiana,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “We will be working with over 150 Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) in Louisiana, providing our iUGO Care software, as well as support services through our call center in Port St Lucie, Florida. We’ll begin onboarding CCM patients to our platform in April and will expand to include BHI patients in Q3 of this calendar year. Each patient on the platform will generate between $30 and $100 USD per month in revenue, depending on the modules and services required for the given patient. We expect to complete onboarding of all patients within the next 12 months.”
Integrating behavioral health care with primary care can improve outcomes for the millions of Americans with mental or behavioral health conditions. Eligible conditions include any mental, behavioral health, or psychiatric condition being treated by the billing practitioner, including substance use disorders. Behavioral health integration enhances standard primary care by adding two key services: care management support for patients receiving behavioral health treatment and regular psychiatric inter-specialty consultation. The iUGO Care Behavioral Health Integration (BHI) module allows clinicians to leverage the billing codes introduced by the Centers for Medicare and Medicaid Services (CMS) for Psychiatric Collaborative Care Model (CoCM) services and General BHI services. The iUGO Care BHI module enables care coordination, secure communication and time tracking for the three clinical roles that must work together to deliver CoCM and General BHI services: the Behavioral Health Care Manager, the Psychiatric Consultant and the Treating (Billing) Practitioner.
About Blum Telehealth
Blum brings together all of your health care providers. Blum can reduce health care costs and expand reach. Blum can reduce health care costs and expand reach for health care providers. Hospitals can refer non-critical patients to practitioners and out of the emergency room. In schools, Blum brings together parent, pediatrician and school nurse to diagnose and treat a sick student without anyone having to leave the office. Almost all facilities can expand reach to underserved populations very cost-efficiently."
Not good news but not too bad. TRST has 6 months to become compliant and remains trading until then.
"CANNTRUST HOLDINGS INC (C-TRST) - News Release
ORIGINAL: CannTrust Receives Continued Listing Notice from the NYSE
2020-02-28 08:57 CT - News Release
TRST Close 2020-02-27 C$ 0.92
VAUGHAN, ON, Feb. 28, 2020 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) announced today that on February 27, 2020 the Company received written notification from the New York Stock Exchange (the "NYSE") that CannTrust is no longer in compliance with the NYSE's continued listing standard rules because the per share trading price of the Company's common shares has fallen below the NYSE's share price rule. The NYSE requires the average closing price of a listed company's common shares to be at least US $1.00 per share over a consecutive 30 trading-day period. As of February 25, 2020, the 30 trading-day average closing price of the Company's common shares was US $0.99.
In accordance with the NYSE's rules, CannTrust has six months from the receipt of the notice to regain compliance. During this time period, the Company's common shares will continue to be listed and trade on the NYSE as usual.
Under NYSE rules, CannTrust can regain compliance at any time during the six-month period if its common shares have a closing price of at least US $1.00 on the last trading day of any calendar month during the period and also have an average closing price of at least US $1.00 over the 30 trading-day period ending on the last trading day of that month or on the last day of the cure period.
Managemnt gives a clarification of possible revenue streams from their new Florida project. The coming webcast in March should be an eye opener for the Market.
"(“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it will go live Monday, March 2, 2020 with Comprehensive Partners in Florida. The Company previously announced that it has signed a contract with Comprehensive to provide the iUGO Care Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform to over 25,000 eligible Medicare patients.
“We are pleased to announce that we will be going live with Comprehensive next week,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “In addition to our iUGO Care Software as a Service, Reliq will be providing implementation and support services to over fifty of Comprehensive Home Care’s Physician Practices from our Call Center in Port St Lucie, Florida. Onboarding to our iUGO Care Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform will start March 2nd and is expected to be completed before the end of the calendar year. Each patient on the platform will generate an average of $35 USD per month in SaaS revenue and up to an additional $52 USD per month from implementation and support service fees. We are pleased to be working with Blum Telehealth to provide a suite of software solutions and services to Comprehensive and their physician partners.”
About Comprehensive Partners
Comprehensive Partners was formed to take advantage of the more than 69 years of combined experience in providing Health Care Services to patients in 193 cities and 39 counties throughout the state of Florida. Through the developed relationships with physician partners and their own knowledge of the health care industry, the ownership team at Comprehensive recognize the needs of patients and promote preventative health programs to maintain the highest quality of life. Learn more at https://www.comprehensivehomehealth.com/.
About Blum Telehealth
Blum is a unique healthcare platform that was designed and developed to disrupt the current closed telehealth market by enabling every stakeholder in the healthcare marketplace to connect and collaborate through one common virtual care platform. The Blum platform allows each stakeholder to build their own private virtual care network which promotes collaboration and continuity, which leads to better outcomes and reduced healthcare cost. Learn more at https://www.blumtelehealth.com/.
About Reliq Health
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits."
Nice to see an insider increases his holding of shares of IP
Early Warning Report
"Identity of Acquirer
1313366 Ontario Inc. (the “Acquirer”)
55 Burbank Drive
Thornhill, ON, L4J 7T9
The transaction described in item 1 above took place on February 26, 2020, and did not
involve any joint actor of the Acquirer.
3. Interest in Securities of the Reporting Issuer
The Acquirer acquired ownership of debentures (the “Subject Debentures”) convertible
into 4,000,000 units of the Company (the “Subject Units”). Each Subject Unit consists of
one common share of the Company (each, a “Subject Share”) and one common share
purchase warrant (each, a “Subject Warrant”). The Subject Debentures represented
approximately 6.4% of all issued and outstanding common shares of the Company as of
February 26, 2020 immediately following the transaction described above, on a partially
diluted basis assuming the conversion of the Subject Debentures and the exercise of the
Subject Warrants only, resulting in a corresponding increase in the percentage of shares
held by the Acquirer as a result of the transaction.
Immediately before the transaction described above, the Acquirer held an aggregate of
4,898,000 common shares of the Company (the “Pre-Shares”), representing approximately
4.2% of the issued and outstanding common shares of the Company.
Immediately following the transaction described above, the Acquirer held an aggregate of
4,898,000 common shares (the “Post-Shares”) and convertible securities, including the
Subject Debentures, entitling the Acquirer to acquire an additional 8,000,000 common
shares of the Company (the “Post-Convertible Securities”), representing approximately
4.2% of the issued and outstanding common shares of the Company (or approximately
10.4% assuming exercise of such Post-Convertible Securities only).
4. Consideration Paid.
The aggregate consideration payable for the Subject Debentures was $200,000. "
Nice to see an insider increases his holding of shares of IP
Early Warning Report
"Identity of Acquirer
1313366 Ontario Inc. (the “Acquirer”)
55 Burbank Drive
Thornhill, ON, L4J 7T9
The transaction described in item 1 above took place on February 26, 2020, and did not
involve any joint actor of the Acquirer.
3. Interest in Securities of the Reporting Issuer
The Acquirer acquired ownership of debentures (the “Subject Debentures”) convertible
into 4,000,000 units of the Company (the “Subject Units”). Each Subject Unit consists of
one common share of the Company (each, a “Subject Share”) and one common share
purchase warrant (each, a “Subject Warrant”). The Subject Debentures represented
approximately 6.4% of all issued and outstanding common shares of the Company as of
February 26, 2020 immediately following the transaction described above, on a partially
diluted basis assuming the conversion of the Subject Debentures and the exercise of the
Subject Warrants only, resulting in a corresponding increase in the percentage of shares
held by the Acquirer as a result of the transaction.
Immediately before the transaction described above, the Acquirer held an aggregate of
4,898,000 common shares of the Company (the “Pre-Shares”), representing approximately
4.2% of the issued and outstanding common shares of the Company.
Immediately following the transaction described above, the Acquirer held an aggregate of
4,898,000 common shares (the “Post-Shares”) and convertible securities, including the
Subject Debentures, entitling the Acquirer to acquire an additional 8,000,000 common
shares of the Company (the “Post-Convertible Securities”), representing approximately
4.2% of the issued and outstanding common shares of the Company (or approximately
10.4% assuming exercise of such Post-Convertible Securities only).
4. Consideration Paid.
The aggregate consideration payable for the Subject Debentures was $200,000. "
As I stated previously, management expects to develop significant revenue from USA agreements.
Here is today's example-hopefully many more to come
" ("Kontrol" or 'Company') a leader in the energy efficiency sector through IoT, Cloud and SaaS technology announces it has received a CDN$405,000 order from a new USA industrial customer for the implementation of a continuous gas emission monitoring system.
The customer operates an industrial glass manufacturing facility and is regulated to deliver continuous emission data at the local and state level. Under the terms of the installation, Kontrol will provide both process control and government regulated emissions monitoring equipment. The installation is anticipated to commence in Q2 2020 and be completed in Q3 2020.
Software and Service Recurring Revenues
Following the completion of the installation Kontrol will deliver ongoing service and software monitoring on a recurring revenue basis and in the approximate amount of $40,000 per annum.
"Given the importance of continuous gas emission regulation and real-time data for local and state governments in the USA, we are anticipating increased demand in the gas emission monitoring sector. This demand for our solutions is further driven by the increase in accountability for greenhouse gas reductions", says Paul Ghezzi, CEO of Kontrol.
Clarification to Press Dated February 24, 2020
As per the press release dated February 24th, 2020 in relation to Kontrol's engagement of Integrous Capital to provide investor relations services in the United States, Kontrol will pay Integrous $12,500 USD per month for a period of 6 months.
First tranche of Financing completed
"Discovery Harbour") is pleased to announce that, further to its news release of February 3, 2020, the Company has closed the first tranche of its non-brokered private placement ("Offering") to raise gross proceeds of $187,500 (the "First Tranche") through the sale of 1,875,000 units priced at $0.10 per unit (each a "Unit"). Each Unit consists of one common share of the Company (each, a "Share") and one half common share purchase warrant, with each whole warrant (each, a "Warrant") entitling the holder to purchase one additional Share at a price of $0.15 for a period of two years from the closing date, subject to an acceleration provision of the Company whereby, if for any ten (10) consecutive trading days the closing price of the Shares on the TSX Venture Exchange (the "Exchange") exceeds $0.25 at any time commencing (4) months after the closing date and until their expiry date, then the remaining term of the Warrants will be reduced to thirty (30) days, commencing seven (7) days from the end of such ten (10) consecutive trading day period. The Company expects to complete the balance of the Offering on or before March 19, 2020.
All securities issued in the First Tranche are subject to a four month hold period expiring June 26, 2020.
Finder's fees of 6% cash ($9,450) and 6% finder's warrants (the "Finder's Warrants") (94,500 Finder's Warrants) were paid to registered representatives on $157,500 of the First Tranche. Each Finder's Warrant is exercisable into one Share at a price of $0.15 per Share for a period of two years from the date of issuance.
The Company plans to use the proceeds from the Offering for development of the Company's Caldera project and for general working capital.
Completion of the Offering is subject to the approval of the Exchange. Any participation by insiders in the Offering will constitute a related party transaction under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101") but is expected to be exempt from the formal valuation and minority shareholder approval requirements of MI 61-101.
None of the securities sold in connection with the private placement will be registered under the United States Securities Act of 1933, as amended, and no such securities may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Latest news from the company
" (CSE: IP) (OTC: IPNFF) is pleased to announce that it has closed its previously announced convertible debenture for an oversubscribed total amount of $1,500,000.
The Company intends to use the proceeds of the financing for marketing, sales, and general corporate purposes.
The debentures will mature on the date that is twenty four months from the date of issuance (the “Issue Date”) and bear interest at a rate of 12% per annum, payable in common shares at a price equal to the closing price on the day before the interest is due and payable. The Debentures are convertible into units at $0.05 per unit. Each unit consists of one common share and one warrant exercisable at $0.10 for a period of three years from the date the Debentures are issued. The Debentures may be converted by the holder at any time prior to maturity and they will automatically convert to units on 30-day notice if the common shares trade at or above $0.20 for a period of 20 days at any time after four months and one day from the Issued Date.
The Debentures and the units issuable upon the conversion of the Debentures will be subject to a statutory resale restriction for four months and one day from the date of closing. Imagination Park may pay finder’s fees in accordance with CSE policies.
Mike Tunnicliffe Appointed to the Board of Directors
Mike Tunnicliffe, who recently joined the Board of Advisors, has now been appointed to the Board of Directors of Imagination Park Technologies Inc.. Mr. Tunnicliffe previously served as EVP, Head of Universal Music Group and Brands-USA. He led Universal Music Group and Brands (UMGB), a music strategy, partnerships and activation division that works closely with all UMG labels, artists and their managements to deliver transformational music-based marketing solutions for brands as well as create new marketing and revenue opportunities for UMG’s artists and labels. Mike, with his team, worked with many Marquee brands including: American Express, Marriott, American Airlines, Honda, Citi, Mars/M&M’s and brokered partnerships with multiple high profile artists including: The Weeknd, Imagine Dragons, X-Ambassadors, Shawn Mendez, Carly Rae Jepson, Keith Urban & Nick Jonas.
About Imagination Park
Imagination Park Technologies Inc. (CSE: IP) (OTC: IPNFF) has developed ImagineAR.com; an “AR-as-a-Service” platform for desktops that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds using ImagineARTM. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The ImagineAR.com mobile app is available in the IOS and Android mobile app stores."
Latest news from the company
" (CSE: IP) (OTC: IPNFF) is pleased to announce that it has closed its previously announced convertible debenture for an oversubscribed total amount of $1,500,000.
The Company intends to use the proceeds of the financing for marketing, sales, and general corporate purposes.
The debentures will mature on the date that is twenty four months from the date of issuance (the “Issue Date”) and bear interest at a rate of 12% per annum, payable in common shares at a price equal to the closing price on the day before the interest is due and payable. The Debentures are convertible into units at $0.05 per unit. Each unit consists of one common share and one warrant exercisable at $0.10 for a period of three years from the date the Debentures are issued. The Debentures may be converted by the holder at any time prior to maturity and they will automatically convert to units on 30-day notice if the common shares trade at or above $0.20 for a period of 20 days at any time after four months and one day from the Issued Date.
The Debentures and the units issuable upon the conversion of the Debentures will be subject to a statutory resale restriction for four months and one day from the date of closing. Imagination Park may pay finder’s fees in accordance with CSE policies.
Mike Tunnicliffe Appointed to the Board of Directors
Mike Tunnicliffe, who recently joined the Board of Advisors, has now been appointed to the Board of Directors of Imagination Park Technologies Inc.. Mr. Tunnicliffe previously served as EVP, Head of Universal Music Group and Brands-USA. He led Universal Music Group and Brands (UMGB), a music strategy, partnerships and activation division that works closely with all UMG labels, artists and their managements to deliver transformational music-based marketing solutions for brands as well as create new marketing and revenue opportunities for UMG’s artists and labels. Mike, with his team, worked with many Marquee brands including: American Express, Marriott, American Airlines, Honda, Citi, Mars/M&M’s and brokered partnerships with multiple high profile artists including: The Weeknd, Imagine Dragons, X-Ambassadors, Shawn Mendez, Carly Rae Jepson, Keith Urban & Nick Jonas.
About Imagination Park
Imagination Park Technologies Inc. (CSE: IP) (OTC: IPNFF) has developed ImagineAR.com; an “AR-as-a-Service” platform for desktops that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds using ImagineARTM. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The ImagineAR.com mobile app is available in the IOS and Android mobile app stores.
RHT management has obviously found a significant mode of operation to increase exposure to a larger population of potential users of their products by secondary players. Along with the previously announced Florida company, here is another major addition to RHT partnership.
"(“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has partnered with MaxMD (Fort Lee, NJ), a leading US provider of secure healthcare information technology and interoperability solutions.
“We are thrilled to partner with MaxMD to leverage the rich data their technology platforms can provide for clinicians, healthcare systems and payors,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “MaxMD has customers in all 50 States and Puerto Rico, and we are excited to introduce their client base to our Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) solutions. MaxMD works with hospitals, outpatient facilities, health departments, commercial payors and Medicare & Medicaid to provide interoperability between all of the health IT systems involved in a patient’s care. This helps streamline care for chronic disease patients, giving providers and payors the opportunity to identify patients who would benefit from case management and other services, such as RPM and CCM, to proactively manage their health conditions and achieve better health outcomes.”
“MaxMD provides standards-based solutions that feed legacy systems the data they need, and supply the most advanced information-sharing capabilities in the industry," says Scott Finlay, CEO of MaxMD. “Healthcare organizations and HIT systems desperate for information that can help improve care coordination, reduce costs, and improve patient outcomes benefit from MaxMD’s innovative approach to standards-based interoperability services. Our solutions increase efficiency in the use of clinical information for quality programs and risk-adjustment analysis, saving the healthcare system money and ensuring that patients benefit from continuity of care across a broad range of settings all the way from the hospital to the home. Working with Reliq will allow us to offer our clients new options to expand access to care, improve health outcomes and reduce healthcare costs by using the iUGO Care Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform.”
About MaxMD
MaxMD is the leader in secure healthcare information technology and interoperability solutions.
Deep technical expertise and industry leadership in the application of Healthcare Information Technology (HIT) standards such as Fast Healthcare Interoperability Resources (FHIR), HL7 Version 2 (V2), Clinical Document Architecture (CDA), public key infrastructure (PKI), USCDI, and the Direct Protocol. MaxMD products enable clients to leverage current and emerging standards through a completely unique approach to data exchange designed to create “scalable data liquidity”. MaxMD’s lightweight data transportation and transformation solutions provide customizable rule sets and real-time delivery of clinical data that supports care coordinators, patients, and payer work flows. By incorporating a sophisticated flexible rules engine, natural language processing, Digital Signature Technology and a highly customized data transformation engine our solution is designed to ease interoperability challenges across the care ecosystem. Delivering the right information in the right format to the right constituent at the right time. The ability to transform data while in transit and leverage the emerging standards such as FHIR, Direct, CDA and USCDI driven by user defined rules and requirements is what differentiates MaxMD.
About Reliq Health
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF."
Todays PR would indicate management sees progress in obtaining exposure to the USA market.
" ("Kontrol" or "Company") today announced that it has retained Integrous Communications as its investor relations advisor for the U.S. Integrous will assist Kontrol in developing and executing a robust corporate communications and investor relations program.
"Given our success in scaling our business to date, we believe it's an opportune time to expand our investor relations and outreach efforts in the U.S.," said Paul Ghezzi, Kontrol's CEO. "We have established a strong track record of growth and are looking forward to accelerating that with existing and new opportunities over the next year. Integrous will provide us with a platform to introduce the Kontrol growth story to the small cap financial markets in the U.S. through a combination of individual meetings, virtual roadshows, traditional roadshows and small cap conferences."
"Kontrol Energy is a perfect fit for Integrous," stated Benjamin Jacobson, Managing Director of Integrous. "Over the past couple of years, management has made tremendous progress in expanding their operations, management team, and customer base. Having recently achieved several important milestones, it is exactly the right time to tell their story to a broader investor audience in the U.S. We look forward to assisting Kontrol and executing on a comprehensive IR strategy for Kontrol over the coming months."
Continuing on its expansion of the company's porfolio of possible revenue producing properties we have the latest addition.
" ("PLAN" or the "Company") is pleased to announce it has signed an option agreement with Jeremy Marlow on a natural pozzolan property in Heffley Creek, BC.
To maintain and exercise the option granted, the Company will pay Mr. Marlow a total amount of $55,000 over a period of 48 months and incur a total of $275,000 in exploration expenditures on the property over a period of 48 months, commencing on the date that the Company receives all necessary prior approvals from the TSXV. Additionally, Mr. Marlow will retain a royalty of $8.00 per tonne of industrial mineral products produced from the property, subject to a 75% buyback right in consideration of $150,000. Mr. Marlow will also retain a 3% NSR Precious Metals Royalty subject to a 50% buyback right in consideration of $1,500,000. No shares will be issued under the option agreement.
PLAN optioned this property after conducting surface sampling which confirmed the presence of alumino-silicates (natural pozzolans), magnesium, and anomalous gold and silver. Five rock samples were taken and one soil sample. PLAN's original interest in the property was for its potential as a further source of natural pozzolans near Kamloops, BC. When surface sampling was done to confirm the presence of natural pozzolans, it revealed the presence of anomalous gold and silver in the soil (0.28 g/tonne gold and 1.6 g/tonne silver). PLAN thus requested the precious metal rights to the property in addition to the industrial mineral rights originally sought. The vendor agreed to option the precious metals rights.
All testing was completed by the Kamloops office of the Metallurgy Division of ALS Global. Whole Rock Analysis was completed on four samples using borate fusion. The Precious Metals Analysis was completed on five samples using fire assay to measure gold, platinum, and palladium. Silver was measured using aqua regia digestion.
All samples were grab samples and are not necessarily representative of the mineralization hosted on the property. PLAN intends to complete more comprehensive soil sampling on the property in the second quarter of 2020 once the snow in the area is melted.
Dwayne Melrose, P. GEO, a qualified person for the purposes of National Instrument 43-101, has reviewed and approved the contents of this news release.
In conjunction with the option agreement, PLAN also signed a consulting agreement with Mr. Marlow whereby Mr. Marlow will assist with exploration work conducted on the property in the first two years of the option agreement. Terms of the consulting agreement including paying Mr. Marlow a minimum of $9,800 in 2020 and an additional $9,800 in 2021 to assist with exploring the Heffley Creek property. In addition, the Consultant will receive 50,000 stock options of PLAN in 2020 and an additional 50,000 stock options in 2021, subject to PLAN's stock option plan and the policies of the TSX Venture Exchange.
Mr. Marlow is an arm's length party to the Company.
The option agreement remains subject to the Company receiving all necessary prior approvals from the TSX Venture Exchange.
PLAN is currently seeking to increase its natural pozzolan assets in the Kamloops area of BC. Pozzolans are receiving more interest from the cement industry as the commercial supply of fly ash is diminishing with the continued closure of coal fired power plants in Alberta and Saskatchewan. Our permitted mine, the Z1 Zeolite Quarry, is located within a one-hour drive of Kamloops and the Z2 Natural Pozzolan Property near Falkland, BC is also approximately a one-
hour drive from Kamloops. Kamloops offer railway access and the ability to serve both the local market, the Lower Mainland of BC and the Calgary to Lethbridge corridor of Alberta.
"I am keen to see this Heffley Creek Property systematically explored. We are excited about its proximity and easy access. It is approximately a 25-minute drive from Kamloops, BC. This property was explored by LaFarge Canada in 1999 where they drilled an alumino-silicate rich area (natural pozzolan) of the property. While our primary interest is the natural pozzolans, we intend to conduct further soil sampling at the property in the Spring of 2020 in search of gold and silver," stated Steve Harpur, CEO.
"It was a pleasure to work again with Steve and the team at PLAN while they did due diligence on the Heffley Creek Property before signing the option agreement. I am excited to see this property further explored for both its industrial mineral content as well as for gold and silver. I am also pleased to be part of the team which will conduct exploration on the property over the next two years," stated Jeremy Marlow.
Progressive Planet is a Canadian based mineral exploration company with its flagship Z1 Zeolite Quarry in Cache Creek, British Columbia. Progressive Planet is committed to using mineral resources to provide solutions for a livable planet."
A significant new start for the latest and possibly,exceptional revenue vehicle in KNR portfolio.
" ("Kontrol" or "Company") a leader in the energy efficiency sector through IoT, Cloud and SaaS technology announces that it has successfully completed its initial commercial pilots, previously announced on December 18, 2019, and will begin production of its leading new energy technology solution for the commercial, multi-residential, hospitality and industrial building markets in Q2 of 2020.
Combining energy management in real-time with rich cloud analytics and smart learning algorithms, the SmartSuite technology is much more than a traditional smart thermostat. In addition, SmartSuite can be deployed rapidly and at a much lower cost than traditional building automation systems.
"We are excited to complete the initial pilot phase of our new technology and are now entering the production and scaling phase," says Kristian Lavereau, COO of Kontrol. "Our SmartSuite technology delivers energy savings in real-time by automating up to 80% of heating and cooling controls and provides instant analysis and feedback through our proprietary cloud solution."
Image: https://www.accesswire.com/users/newswire/images/577522/bf35d519-c9f7-48ce-a373-1b8957448adc.png
Pricing and Market
Each SmartSuite can be installed, on a turn-key basis, for less than $500 or can be purchased by customers on a software as a service (SaaS) basis under a 5-year agreement. In many jurisdictions in Canada and the US and subject to the local utility policy the SmartSuite may qualify as an energy savings technology and may eligible for applicable incentives.
For a typical Kontrol customer in the multi-residential (apartment) sector operating a building of up to 400 apartment units the SmartSuite can be installed for approximately $200,000 (entire building). Based on a typical energy profile the SmartSuite can deliver approximately $90,000 per year in energy savings and deliver an approximate 2 year pay-back to the customer. By increasing net operating income through the reduction of energy costs, the SmartSuite technology will also provide an increase in building value.
Sales Pipeline and Strategy
With approximately 15,000 units of the previous version of the SmartSuite installed and operating across Canada, Kontrol has an established customer base that will be presented an upgrade opportunity to next generation of the technology. Beginning in Q2 2020 Kontrol will initiate upgrade opportunities for each of its customers.
U.S. and Middle East Markets
Following the completed pilots in Canada, Kontrol is focused on selecting potential pilot sites and customers in the U.S and Saudi Arabia."
Fabulous news for Flower and naturally the collapse of the Market drops the share price.
Frustrating isn't it!!
"THE FLOWR CORPORATION RECEIVES HEALTH CANADA APPROVAL TO DOUBLE CURRENT CAPACITY AT FLAGSHIP KELOWNA 1 FACILITY WHICH IS NOW FULLY OPERATIONAL
The Flowr Corp. has received approval from Health Canada to open 10 additional grow rooms at its Kelowna 1 cultivation facility, bringing the total to 20, doubling the company's capacity to grow premium, indoor flower at the facility and enabling automation to lower cost of goods sold. This is the final approval required for full operation of the facility.
Kelowna 1 is Flowr's premier purpose-built indoor cultivation facility located in the Okanagan Valley of British Columbia. Following receipt of the new Health Canada approval, the Company plans to immediately begin phasing in the propagation of these additional grow rooms and expects the 85,000 square foot facility to produce, at ultimate capacity, approximately 10,000 kilograms of premium cannabis flower on an annualized basis.
"The full licensing of Kelowna 1 is a major milestone for Flowr. For the first time since we broke ground on the facility we won't be operating out of a construction site. We continue to see growing demand for our premium cannabis products led by our flagship strain, Pink Kush. Furthermore, we expect to see an improvement in operating efficiency as we reach scale coupled with the commissioning of our automated packaging line," said Vinay Tolia, CEO of Flowr.
Flowr's cultivation facilities are being constructed to Good Manufacturing Practice (GMP) standards. They employ proprietary designs and systems to create a highly controlled growing environment that the Company expects will enable it to produce a large portion of its premium cannabis without requiring irradiation to meet Health Canada standards. The Company's cultivation team follows exacting protocols throughout the growing process then carefully harvests, trims and cures its products, seeking to deliver a premium experience for consumers.
About The Flowr Corporation
The Flowr Corporation is a Toronto-headquartered cannabis company with operations in Canada, Europe, and Australia. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility that is currently under construction. From this campus, Flowr produces recreational and medicinal products. Internationally, Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and will operate GMP-designed manufacturing facilities in Portugal and Australia."
Not really. We need to see completion of all deals before management will star development.At least that is my take.
Well at least there are 2 of us!!
Misery loves company.